Quick Takeaways
- Jeffrey Humphrey has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $749,950.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Jeffrey Humphrey and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LNTH | Lantheus Holdings, Inc. | Chief Medical Officer | $749,950 | 17 Jun 2024 | ||
| CNST | CONSTELLATION PHARMACEUTICALS INC | Chief Medical Officer | 15 Jul 2021 | |||
| CYT | Cyteir Therapeutics, Inc. | Director | 03 Feb 2023 | |||
| DNTH | Magenta Therapeutics, Inc. | Chief Medical Officer | 01 Aug 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|